# Phase 2 Clinical Trial to Investigate the Safety, Tolerability and Efficacy of YH1885L in Patients With Non-erosive Reflux Disease(NERD)

> **NCT01750437** · PHASE2 · COMPLETED · sponsor: **Yuhan Corporation** · enrollment: 149 (actual)

## Conditions studied

- Non-erosive Reflux Disease

## Interventions

- **DRUG:** YH1885L(Revaprazan)
- **DRUG:** Esomeprazole 20mg
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01750437
- **Lead sponsor:** Yuhan Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2013-10
- **Final completion:** 2014-04
- **Target enrollment:** 149 (ACTUAL)
- **Last updated:** 2014-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01750437

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01750437, "Phase 2 Clinical Trial to Investigate the Safety, Tolerability and Efficacy of YH1885L in Patients With Non-erosive Reflux Disease(NERD)". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01750437. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*